Kraft, GSK, and BASF announcements illustrate convergence of food, cosmetics, chemicals, and medicine

The distance between food, cosmetics, chemicals, and medicine keeps shrinking, as evidenced by several recent commercial announcements. Back in May, food giant Kraft and its partner Medisyn, which specializes in discovery of novel active ingredients, announced an expansion of their collaboration fro...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email Thank you!

Related Research

Seed Health

Company Snapshot | February 10, 2021

The company was started by Ara Katz and Raja Dhir (co‑CEOs); Dr. Gregor Reid, a well‑known scientist in the probiotics and microbiome modulation space, is the chief scientist and is on the scientific advisory board of Seed, its consumer‑facing arm. Among its investors, we emphasize Bold Capital, 8VC... To read more, click here.

Proteon Pharmaceuticals raises $24.6 million for rolling out bacteriophage therapies globally

News Commentary | August 13, 2021

The round was co‑led by Nutreco and Aqua‑Spark and joined by PFR Life Science, Montis Capital, Seventure Partners, and others. Proteon will use the funds for the commercialization and global rollout of its bacteriophage therapies for livestock and to develop new solutions to prevent mastitis in ... Not part of subscription

Brightseed raises USD 68 million to accelerate discovery and novel functional ingredient commercialization

News Commentary | May 11, 2022

Brightseed secured USD 68 million in funding led by Temasek to allow their artificial intelligence‑backed discovery tool "Forager" to continue mining healthful compounds in waste streams and grow partnerships like the one established with Danone. The biggest change will come if the company is able ... Not part of subscription